Led by Catherine Pihoker, MD, the TrialNet team at Seattle Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Seattle Children's Hospital is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution.